Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Jul;94(7):1127-32.
doi: 10.2105/ajph.94.7.1127.

Psychosocial characteristics of New York City HIV-infected women before and after the advent of HAART

Karolynn Siegel  1 , Daniel Karus, Laura Dean
Affiliations

Psychosocial characteristics of New York City HIV-infected women before and after the advent of HAART

Karolynn Siegel et al. Am J Public Health. 2004 Jul.

Abstract

Objectives: We compared level of psychosocial distress of HIV-infected women living in New York City before the advent of highly active antiretroviral therapy (HAART) with level of psychosocial distress reported by women living with the disease after the use of HAART became widespread.

Methods: Data were from HIV-positive New York City women aged 18 to 50 years, enrolled through outreach and self-referral. We compared scores on measures of psychological state and psychosocial adjustment to illness of 74 women interviewed in 1994-1996 with scores of a matched group of 74 women interviewed in 2000-2002.

Results: A significant difference between groups was found only with regard to adjustment to illness in their domestic environment, with poorer adjustment reported, on average, by women in the 2000-2002 sample.

Conclusions: Although new treatments have significantly improved the physical health of those living with HIV/AIDS, no evidence was found that these treatments significantly improved psychological health for women, regardless of history of protease inhibitor use.

PubMed Disclaimer

References

    1. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–860. - PubMed
    1. Detels R, Munoz A, McFarlame G, et al. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. JAMA. 1998;280:1497–1503. - PubMed
    1. Kobayashi JS. The evolution of adjustment issues in HIV/AIDS. Bull Menninger Clin. 1997;61:146–188. - PubMed
    1. Rabkin JG, Ferrando SJ. A “second life” agenda. Psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome. Arch Gen Psychiatry. 1997;54:1049–1053. - PubMed
    1. Kalichman SC, Ramachandran B. Mental health implications of new HIV treatments. In: Ostrow DG, Kalichman SC, eds. Psychosocial and Public Health Impacts of New HIV Therapies. New York, NY: Kluwer Academic/Plenum Publishers; 1995:137–150.

Publication types

MeSH terms

Substances